-
Je něco špatně v tomto záznamu ?
Organic Salts of Pharmaceutical Impurity p-Aminophenol
UBR. Khandavilli, L. Keshavarz, E. Skořepová, RRE. Steendam, PJ. Frawley
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
12/RC/2275
Science Foundation Ireland - Ireland
17-23196S
Grantová Agentura České Republiky
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- aminofenoly chemie MeSH
- kontaminace léku * MeSH
- krystalografie rentgenová MeSH
- léčivé přípravky analýza chemie normy MeSH
- molekulární modely MeSH
- molekulární struktura MeSH
- organické látky chemie MeSH
- prášky, zásypy, pudry MeSH
- soli chemie MeSH
- Publikační typ
- časopisecké články MeSH
The presence of impurities can drastically affect the efficacy and safety of pharmaceutical entities. p-Aminophenol (PAP) is one of the main impurities of paracetamol (PA) that can potentially show toxic effects such as maternal toxicity and nephrotoxicity. The removal of PAP from PA is challenging and difficult to achieve through regular crystallization approaches. In this regard, we report four new salts of PAP with salicylic acid (SA), oxalic acid (OX), l-tartaric acid (TA), and (1S)-(+)-10-camphorsulfonic acid (CSA). All the PAP salts were analyzed using single-crystal X-ray diffraction, powder X-ray diffraction, infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis. The presence of minute amounts of PAP in paracetamol solids gives a dark color to the product that was difficult to remove through crystallization. In our study, we found that the addition of small quantities of the aforementioned acids helps to remove PAP from PA during the filtration and washings. This shows that salt formation could be used to efficiently remove challenging impurities.
Institute of Physics ASCR Na Slovance 2 182 21 Praha 8 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012691
- 003
- CZ-PrNML
- 005
- 20210507103644.0
- 007
- ta
- 008
- 210420s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules25081910 $2 doi
- 035 __
- $a (PubMed)32326160
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Khandavilli, U B Rao $u Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland $u PSC Biotech Limited, Blanchardstown, Dublin 15, Ireland
- 245 10
- $a Organic Salts of Pharmaceutical Impurity p-Aminophenol / $c UBR. Khandavilli, L. Keshavarz, E. Skořepová, RRE. Steendam, PJ. Frawley
- 520 9_
- $a The presence of impurities can drastically affect the efficacy and safety of pharmaceutical entities. p-Aminophenol (PAP) is one of the main impurities of paracetamol (PA) that can potentially show toxic effects such as maternal toxicity and nephrotoxicity. The removal of PAP from PA is challenging and difficult to achieve through regular crystallization approaches. In this regard, we report four new salts of PAP with salicylic acid (SA), oxalic acid (OX), l-tartaric acid (TA), and (1S)-(+)-10-camphorsulfonic acid (CSA). All the PAP salts were analyzed using single-crystal X-ray diffraction, powder X-ray diffraction, infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis. The presence of minute amounts of PAP in paracetamol solids gives a dark color to the product that was difficult to remove through crystallization. In our study, we found that the addition of small quantities of the aforementioned acids helps to remove PAP from PA during the filtration and washings. This shows that salt formation could be used to efficiently remove challenging impurities.
- 650 _2
- $a aminofenoly $x chemie $7 D000627
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 12
- $a kontaminace léku $7 D004340
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a organické látky $x chemie $7 D009930
- 650 _2
- $a léčivé přípravky $x analýza $x chemie $x normy $7 D004364
- 650 _2
- $a prášky, zásypy, pudry $7 D011208
- 650 _2
- $a soli $x chemie $7 D012492
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Keshavarz, Leila $u Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland
- 700 1_
- $a Skořepová, Eliška $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 16628 Prague 6, Czech Republic $u Institute of Physics ASCR, Na Slovance 2, 182 21 Praha 8, Czech Republic
- 700 1_
- $a Steendam, René R E $u Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland
- 700 1_
- $a Frawley, Patrick J $u Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 25, č. 8 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32326160 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507103643 $b ABA008
- 999 __
- $a ok $b bmc $g 1650954 $s 1133070
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 25 $c 8 $e 20200421 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a 12/RC/2275 $p Science Foundation Ireland $2 Ireland
- GRA __
- $a 17-23196S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20210420